140 related articles for article (PubMed ID: 2573284)
21. Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice.
Huber SA; Lodge PA
Am J Pathol; 1986 Feb; 122(2):284-91. PubMed ID: 3004227
[TBL] [Abstract][Full Text] [Related]
22. The role of B lymphocytes in coxsackievirus B3 infection.
Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
[TBL] [Abstract][Full Text] [Related]
23. Antigen-specific suppressor T cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3.
Estrin M; Smith C; Huber S
Am J Pathol; 1986 Dec; 125(3):578-84. PubMed ID: 2432792
[TBL] [Abstract][Full Text] [Related]
24. Monocytic myeloid-derived suppressor cells from females, but not males, alleviate CVB3-induced myocarditis by increasing regulatory and CD4(+)IL-10(+) T cells.
Su N; Yue Y; Xiong S
Sci Rep; 2016 Mar; 6():22658. PubMed ID: 26939768
[TBL] [Abstract][Full Text] [Related]
25. TLR3 is required for survival following Coxsackievirus B3 infection by driving T lymphocyte activation and polarization: The role of dendritic cells.
Sesti-Costa R; Françozo MCS; Silva GK; Proenca-Modena JL; Silva JS
PLoS One; 2017; 12(10):e0185819. PubMed ID: 28973047
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune response in chronic ongoing myocarditis demonstrated by heterotopic cardiac transplantation in mice.
Nakamura H; Yamamura T; Umemoto S; Fukuta S; Shioi T; Matsumori A; Sasayama S; Matsuzaki M
Circulation; 1996 Dec; 94(12):3348-54. PubMed ID: 8989150
[TBL] [Abstract][Full Text] [Related]
27. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
28. Naturally occurring anti-idiotypic antibodies--mechanisms for autoimmunity and immunoregulation?
Weremeichik H; Moraska A; Herzum M; Weller A; Huber SA
Eur Heart J; 1991 Aug; 12 Suppl D():154-7. PubMed ID: 1655445
[TBL] [Abstract][Full Text] [Related]
29. Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms.
Lodge PA; Herzum M; Olszewski J; Huber SA
Am J Pathol; 1987 Sep; 128(3):455-63. PubMed ID: 2957924
[TBL] [Abstract][Full Text] [Related]
30. Coxsackievirus B-3 myocarditis. T-cell autoimmunity to heart antigens is resistant to cyclosporin-A treatment.
Estrin M; Smith C; Huber S
Am J Pathol; 1986 Nov; 125(2):244-51. PubMed ID: 3024491
[TBL] [Abstract][Full Text] [Related]
31. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
[TBL] [Abstract][Full Text] [Related]
32. T cells expressing the gamma delta T-cell receptor potentiate coxsackievirus B3-induced myocarditis.
Huber SA; Moraska A; Choate M
J Virol; 1992 Nov; 66(11):6541-6. PubMed ID: 1328680
[TBL] [Abstract][Full Text] [Related]
33. Coxsackievirus B3 infection promotes generation of myeloid dendritic cells from bone marrow and accumulation in the myocardium.
Chen P; Chen R; Yang Y; Yu Y; Xie Y; Zou Y; Ge J; Chen H
Int Immunopharmacol; 2009 Oct; 9(11):1304-12. PubMed ID: 19664723
[TBL] [Abstract][Full Text] [Related]
34. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
35. Dual functions of murine gammadelta cells in inflammation and autoimmunity in coxsackievirus B3-induced myocarditis: role of Vgamma1+ and Vgamma4+ cells.
Huber SA; Born W; O'Brien R
Microbes Infect; 2005 Mar; 7(3):537-43. PubMed ID: 15777711
[TBL] [Abstract][Full Text] [Related]
36. Polyclonal immunoglobulin therapy protects against cardiac damage in experimental coxsackievirus-induced myocarditis.
Weller AH; Hall M; Huber SA
Eur Heart J; 1992 Jan; 13(1):115-9. PubMed ID: 1349527
[TBL] [Abstract][Full Text] [Related]
37. Immunopathogenesis of experimental Coxsackievirus induced myocarditis: role of autoimmunity.
Huber SA; Lyden DC; Lodge PA
Herz; 1985 Feb; 10(1):1-7. PubMed ID: 2984097
[TBL] [Abstract][Full Text] [Related]
38. Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsakieviral myocarditis.
Huber SA; Cunningham MW
J Immunol; 1996 May; 156(9):3528-34. PubMed ID: 8617982
[TBL] [Abstract][Full Text] [Related]
39. An attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo.
Loudon RP; Moraska AF; Huber SA; Schwimmbeck P; Schultheiss P
J Virol; 1991 Nov; 65(11):5813-9. PubMed ID: 1656071
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.
Zhang H; Yousef GE; Ouyang X; Archard LC
Int J Exp Pathol; 1994 Apr; 75(2):99-110. PubMed ID: 8199011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
